MRKR — Marker Therapeutics, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1094038 ·
Last close
$0.84
Market Cap
$13.95M
52W High
$2.46
52W Low
$0.81
ADV30
169,847
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -1,936,257 -1,844,472 12,499,291 9,039,785 1,996,412
Jun 2026 0 — -1,938,787 -1,826,229 14,585,485 11,331,023 2,420,021
Mar 2026 0 — -3,320,844 -3,179,278 17,434,008 14,915,519 3,638,050
Dec 2025 0 — -1,883,994 -1,703,210 19,070,997 16,068,048 2,274,183

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-9,756,497
Investing CF
—
Financing CF
$9,863,883
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.66
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-464,186,305
Inventory
—
Receivables
$1,619,477
ST Investments
—
EBIT TTM
$-9,280,351
Pretax Income TTM
$-8,722,535
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$3,546,669
EBITDA
—
Free Cash Flow
$-6,227,035
Enterprise Value
$7,843,073
Total Cash
$11,331,023
Total Debt
$0
Shares Out
16,673,127
Trailing EPS
$-0.38
Book Value
$0.73
ROE
-76.9%
ROA
-40.5%
Div Yield
—

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -12,437,291 -12,163,620 19,070,997 2,274,183 16,796,814 -12,014,081
Dec 2024 0 -11,118,372 -10,731,315 22,022,860 3,464,454 18,558,406 -10,910,324
Dec 2023 3,311,133 -11,270,245 -8,236,814 17,127,391 3,074,848 14,052,543 -16,439,961
Dec 2022 0 -19,791,004 -29,930,694 34,422,184 14,821,147 19,601,037 -26,972,153
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$2,581,828
NetIncome TTM
$-8,707,379
OpCashFlow TTM
—
Assets (Latest)
$14,585,485
Forward EPS
$-0.53

Peers — same industry

TickerNameMarket CapLastDaily %
INTI Inhibitor Therapeutics, Inc. $13.98M $0.08 —
ACTU ACTUATE THERAPEUTICS, INC. $13.84M $0.25 —
CTXR Citius Pharmaceuticals, Inc. $14.24M $0.52 —
MCRB Seres Therapeutics, Inc. $14.37M $1.41 —
SYBX SYNLOGIC, INC. $13.47M $1.10 —

News headlines (Yahoo Finance, 1h cache)

MARKER THERAPEUTICS, INC. (MRKR) Reports Q3 Loss, Lags Revenue Estimates
2026-11-16 22:50 · Yahoo
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
2026-10-19 11:00 · Yahoo
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
2026-10-16 15:00 · Yahoo
New Strong Buy Stocks for October 16th
2026-10-16 07:04 · Yahoo
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
2026-09-22 12:00 · Yahoo
High Growth Tech Stocks To Watch In US June 2026
2026-06-03 11:38 · Yahoo
Rigel Pharmaceuticals (RIGL) Misses Q3 Earnings Estimates
2026-11-06 00:00 · Yahoo
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
2026-08-06 13:50 · Yahoo
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
2026-06-26 08:59 · Yahoo
US High Growth Tech Stocks with Promising Potential
2026-06-05 11:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.